ALKYLAMINE
Alkyl Amines Chemicals share price & financials
- Price
- ₹1,826.9
- Market cap
- ₹9.5k Cr
- Sector
- Chemicals
- Calls analysed
- 3
Alkyl Amines Q4 FY26
What went well
- Managed to retain and perhaps even slightly increase market share in various markets.
- Successfully overcame operational challenges related to ammonia sourcing in March.
- Acetonitrile pricing improved towards year-end, leading to increased volumes and market share.
What to watch
- Markets have not grown as fast as desired.
- Future remains uncertain due to ongoing war, impacting supply chains.
What Alkyl Amines Chemicals Limited does
Alkyl Amines Chemicals Limited (AACL) manufactures aliphatic amines, amine derivatives and specialty chemicals used by customers in pharmaceutical, agrochemical, dyes, rubber, surfactant and other industries to add value to their end products. It runs over 20 production plants across three manufacturing sites in Maharashtra and Gujarat, offering more than 100 products, and is a global leader or sole global producer for several of them, including synthetic Acetonitrile, DMAHCL, Triethylamine and Diethylhydroxylamine. The company earns by selling both bulk aliphatic amines and higher-value amine derivatives and specialty chemicals domestically and via exports.
Segments
- Specialty Chemicals
- Manufacturing sites
- 3 (Patalganga, Kurkumbh, Dahej)
- Installed capacity across plants
- ~158,000 TPA (18,000 + 65,000 + 75,000 TPA)
- Production plants
- 20+ plants across three sites
- Land under manufacturing
- 110+ acres (Maharashtra & Gujarat)
- Product portfolio
- 100+ products
- Export footprint
- 50+ countries across six continents
Guidance record · Q4 FY26
what the last two calls moved 8 tracked 1 delivered 3 missed 4 open- Acetonitrile Anti-Dumping Duty Benefit delivered, diluted said Q4 FY25 Promised: Impact expected after 90-100 day MoF approval window Q4 FY26: Management confirmed that towards the end of the year, pricing and volumes for acetonitrile improved as Chinese competitors eased aggressive pricing, partially realizing the benefits of the anti-dumping duty as guided in Q2.
- FY26 Volume Growth missed said Q4 FY25 Promised: 10% to 15% double digit growth Q4 FY26: Management confirmed FY26 volume growth was flat, with tonnage up by only 1% YoY, missing the original 10-15% target and confirming the 'subdued' revision.
- New Product Mechanical Completion delayed said Q4 FY25 Promised: December 2025 or January 2026 Q4 FY26: Mechanical completion timeline pushed again to the end of June 2026, with commissioning now expected in early Q1 FY27. This is a further delay from the previously revised Feb-Mar 2026 target.
All 8 tracked — every revision, and every one management stopped mentioning.
Open the guidance ledgerQuarterly results
Q1 FY27: revenue up 30.0%, net profit up 93.9% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 415 | 371 | 386 | 406 | 389 −6% | 354 −5% | 387 +0% | 528 +30% |
| EBITDA | 74 | 71 | 68 | 77 | 70 −5% | 67 −6% | 71 +4% | 134 +74% |
| Net profit | 47 | 44 | 46 | 49 | 43 −9% | 42 −5% | 45 −2% | 95 +94% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −9.7% 1Y
1Y: ₹2,068.8 on 10 Sept 2025 → ₹1,867.5. High ₹2,093.8 (17 Sept 2025), low ₹1,231.6 (30 Mar 2026).
How the price took the results
close before → close after
- Q4 FY26
- +14.0%
- 6 May
- Q2 FY26
- −1.5%
- 6 Nov
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Financials, as filed
Revenue grew 12.7% a year over 5 years, FY19 to FY26. Operating margin narrowed to 18.6%.
| Year ending | FY19 | FY20 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | ₹846 Cr | ₹993 Cr | ₹1.7k Cr | ₹1.4k Cr | ₹1.6k Cr | ₹1.5k Cr |
| Operating profit | ₹163 Cr | ₹258 Cr | ₹345 Cr | ₹251 Cr | ₹292 Cr | ₹285 Cr |
| Operating margin | 19.3% | 26.0% | 20.5% | 17.4% | 18.6% | 18.6% |
| Interest | ₹15 Cr | ₹11 Cr | ₹4 Cr | ₹5 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹24 Cr | ₹27 Cr | ₹46 Cr | ₹59 Cr | ₹72 Cr | ₹72 Cr |
| Net profit | ₹87 Cr | ₹201 Cr | ₹229 Cr | ₹148 Cr | ₹186 Cr | ₹179 Cr |
| Net margin | 10.3% | 20.2% | 13.6% | 10.3% | 11.8% | 11.7% |
| Cash from operations | ₹144 Cr | ₹188 Cr | ₹248 Cr | ₹275 Cr | ₹263 Cr | ₹239 Cr |
| Free cash flow | ₹75 Cr | ₹111 Cr | ₹-55 Cr | ₹153 Cr | ₹216 Cr | ₹111 Cr |
| ROCE | 28.0% | 41.0% | — | — | — | — |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr |
| Reserves | ₹782 Cr | ₹980 Cr | ₹1.2k Cr | ₹1.3k Cr | ₹1.4k Cr | ₹1.5k Cr |
| Borrowings | ₹47 Cr | ₹23 Cr | ₹88 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr |
| Other liabilities | ₹306 Cr | ₹359 Cr | ₹335 Cr | ₹314 Cr | ₹322 Cr | ₹362 Cr |
| Total liabilities | ₹1.1k Cr | ₹1.4k Cr | ₹1.6k Cr | ₹1.6k Cr | ₹1.8k Cr | ₹1.9k Cr |
| Fixed assets | ₹458 Cr | ₹629 Cr | ₹719 Cr | ₹1.1k Cr | ₹1.0k Cr | ₹1.0k Cr |
| Capital work in progress | ₹138 Cr | ₹143 Cr | ₹352 Cr | ₹36 Cr | ₹76 Cr | ₹130 Cr |
| Investments | ₹30 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹51 Cr |
| Other assets | ₹520 Cr | ₹600 Cr | ₹521 Cr | ₹459 Cr | ₹651 Cr | ₹700 Cr |
| Total assets | ₹1.1k Cr | ₹1.4k Cr | ₹1.6k Cr | ₹1.6k Cr | ₹1.8k Cr | ₹1.9k Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, the public trimmed −0.75 pp while DIIs added +0.50 pp. The shareholder count shrank 11% to 1,42,625.
- Promoters
- 72.0%
- FIIs
- 3.5%
- DIIs
- 3.1%
- Public
- 21.4%
Since Jun 2025
- Public −0.75 pp
- DIIs +0.50 pp
- FIIs +0.24 pp
How it drifted, 12 quarters
Over this window the public fell from 24.0% to 21.4% — −2.6 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 72.0%, FIIs 2.9%, DIIs 1.1%, Public 24.0%.Dec '23: Promoters 72.0%, FIIs 2.9%, DIIs 1.1%, Public 24.1%.Mar '24: Promoters 72.0%, FIIs 3.0%, DIIs 1.1%, Public 23.9%.Jun '24: Promoters 72.0%, FIIs 3.1%, DIIs 1.1%, Public 23.9%.Sep '24: Promoters 72.0%, FIIs 3.2%, DIIs 1.5%, Public 23.3%.Dec '24: Promoters 72.0%, FIIs 3.2%, DIIs 1.8%, Public 23.0%.Mar '25: Promoters 72.0%, FIIs 3.2%, DIIs 2.2%, Public 22.5%.Jun '25: Promoters 72.0%, FIIs 3.3%, DIIs 2.6%, Public 22.1%.Sep '25: Promoters 72.0%, FIIs 3.4%, DIIs 2.9%, Public 21.7%.Dec '25: Promoters 72.0%, FIIs 3.5%, DIIs 3.0%, Public 21.5%.Mar '26: Promoters 72.0%, FIIs 3.5%, DIIs 3.0%, Public 21.5%.Jun '26: Promoters 72.0%, FIIs 3.5%, DIIs 3.1%, Public 21.4%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- HSBC Mutual Fund - HSBC Small Cap Fund Mutual fund newly disclosed 1.02% held
The same filing shows 0 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Alkyl Amines Chemicals Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Yogesh Mathradas Kothari | 57.64% | unchanged |
| Niyoko Trading And Consultancy Llp | 3.83% | unchanged |
| Purjeeko Trading & Consultancy Llp | 3.81% | unchanged |
| Nini Yogesh Kothari | 2.48% | unchanged |
| Ikigai Emerging Equity Fund AIF | 1.60% | unchanged |
| Syk Trading And Consultancy Llp | 1.54% | unchanged |
| Hemendra Mathradas Kothari | 1.04% | unchanged |
| HSBC Mutual Fund - HSBC Small Cap Fund Mutual fund | 1.02% | newly disclosed |
| Suneet Yogesh Kothari | 0.75% | unchanged |
| Anjyko Investments Pvt Ltd | 0.26% | unchanged |
| Devangana Jayant Desai | 0.15% | unchanged |
| Kunjlata N Shah | 0.15% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
What the price assumes
Growth trapTo justify its price of ₹1868, this stock must grow earnings at 28% every year for 7 years. Our analysis caps realistic growth at ~-8%. At that growth it is worth ₹286 — downside of 85%.
- Growth the price implies
- 27.6% a year
- for 7 years, fading to 4%
- It has actually compounded at
- -7.9% a year
- net profit, FY23–FY26 · EPS -7.7%
- The gap
- 0.4 pp
- -85% downside if it only repeats history
All earnings calls (3)
Read the Q4 FY26 call →Learn to analyse Alkyl Amines Chemicals Limited
Guides on how to read this kind of business and the numbers that matter.